We showed that phosphorylation of ARHGAP18 by PKN3 leads to activation of its GAP domain and contributes to regulation of active RhoA levels, implying the possible crosstalk of PKN3 and ARHGAP18 signaling in cancer and other diseases. Here, RHOA is linked to cancer.